For example, ~40% of patients with advanced hormone receptor-positive, human epidermal growth factor receptor 2-negative (HER2–) breast cancer demonstrate activating mutations in the PI3K catalytic subunit alpha (PIK3CA) gene, which encodes the p110α-isoform of PI3K (1, 2). The gene discussed is ERBB2; the disease is breast carcinoma.